Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hybridoma cell line XMMBR-B14 and monoclonal antibody which is specific for a non-cross reactive epitope of CEA

Hybridoma cell line XMMBR-B14 and monoclonal antibody which is specific for a non-cross reactive epitope of CEA

US Patent 4853464 · Granted Aug 1, 1989

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition containing CEA/NCA-specific monoclonal antibody XMMBR-B14 conjugated1993
Composition containing CEA/NCA-specific monoclonal antibody XMMBR-B14 conjugated1993
Methods and compositions for screening carcinomas1992
Methods and compositions for screening carcinomas1992
Method for predicting chemosensitivity of anti-cancer drugs1990
Method for predicting chemosensitivity of anti-cancer drugs1989
Enhanced growth medium and method for culturing human mammary epithelial cells1983